Cutler Group LP Genetic Technologies LTD Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$0.0 - $0.01 $0 - $1	-100 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$0.0 - $0.02 $0 - $178	-8,900 Reduced 98.89%	100 $0
Q1 2021 Apr 26, 2021	BUY	$0.0 - $0.01 $0 - $39	3,947 Added 78.11%	9,000 $37,000
Q4 2020 Jan 21, 2021	BUY	$0.0 - $0.0 $0 - $0	4,528 Added 862.48%	5,053 $18,000
Q3 2020 Oct 27, 2020	SELL	$0.0 - $0.0 $0 - $0	-300 Reduced 36.36%	525 $1,000

Q1 2020 May 07, 2020	SELL	$0.0 - $0.0 $0 - $0	-500 Reduced 37.74%	825 $1,000
Q3 2019 Oct 28, 2019	BUY	$0.0 - $0.0 $0 - $0	1,325 New	1,325 $2,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $19.1M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.